Effect of single preoperative dose of tranexamic acid on blood loss and transfusion in hip arthroplasty;Wpływ jednorazowej przedoperacyjnej dawki kwasu traneksamowego na utratę krwi i ilość transfuzji przy aloplastyce stawu biodrowego

Ortopedia Traumatologia Rehabilitacja

Volumn 17, Issue 3, 2015, Pages 265-273

  Jaszczyk, Marcin ^a   Kozerawski, Dariusz ^a   Kołodziej, Łukasz ^b   Kazimierczak, Arkadiusz ^b   Sarnecki, Patryk ^a   Sieczka, Łukasz ^b  

^a Department V of Trauma and Orthopaedic Surgery A Soko owski Specialist Hospital   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Blood loss; Blood transfusion; Hip arthroplasty; Thromboembolic complications; Tranexamic acid

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

ADULT; AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; COMPARATIVE STUDY; FEMALE; HIP REPLACEMENT; HUMAN; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; PROCEDURES; THROMBOEMBOLISM; TREATMENT OUTCOME; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE CARE; THROMBOEMBOLISM; TRANEXAMIC ACID; TREATMENT OUTCOME;

EID: 84938677048     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: 10.5604/15093492.1162426     Document Type: Article

References (23)

1. Paluszkiewicz P. Przetaczanie krwi i jej składników w chirurgii i traumatologii. W: Korsak J, Łętowska M, editors. Transfuzjo-lo gia kliniczna. Łódź: Medica Press; 2009. p.139-149.
2. Bagsby DT, Hur J. Effect of Intra-articular Injection of Tranexamic Acid on Postoperative Hemoglobin in Total Hip Arthro-plasty. Orthopedics 2014; 37(6): 557-62.
3. Joy PJ, Bennet SJ. The appropriateness of blood transfusion following primary total hip replacement. Ann R Coll Surg Engl 2012; 94(3): 201-3.
4. Dobosz B, Dutka J, Dutka Ł, Maleta P. Znaczenie kliniczne i ekonomiczne retransfuzji krwi w aloplastykach stawu biodro-wego i kolanowego. Ortop Traumatol Rehabil 2012; 5(6): 421-8.
5. Lemaire R. Strategies for blood management in orthopaedic and trauma surgery. J Bone Joint Surg Br 2008; 90(9): 1128-36.
6. Cardone D, Klein AA. Perioperative blood conservation. Eur J Anaesthesiol 2009; 26(9): 722-9.
7. Rajesparan K, Biant LC, Ahmad M, Field RE. The effect of an intravenous bolus of tranexamic acid on blood loss in total hip replacement. J Bone Joint Surg Br 2009; 91(6): 776-83.
8. Mahdy AM, Webster NR. Perioperative systemic haemostatic agents. Br J Anaesth 2004; 93: 842-58.
9. Horrow JC, Van Riper DF, Strong MD, Brodsky I, Parmet JL. Hemostatic effects of tranexamic acid and desmopressin during cardiac surgery. Circulation 1991; 84(5): 2063-70.
10. Ickx BE, Van Der Linden PJ, Melot C, et al. Comparison of the effects of aprotinin and tranexamic acid on blood loss and red blood cell transfusion requirements during the late stages of liver transplantation. Transfusion 2006; 46(4): 595-605.
11. Malhotra R, Kumar V, Garg B. The use of tranexamic acid to reduce blood loss in primary cementless total hip arthroplasty. Eur J Orthop Surg Traumatol 2010; 21: 101-4.
12. Claeys MA, Vermeersch N, Haentjens P. Reduction of blood loss with tranexamic acid in primary total hip replacement surgery. Acta Chir Belg 2007; 107: 397-401.
13. Kazemi SM, Mosaffa F, Eajazi A, et al. The effect of tranexamic acid on reducing blood loss in cementless total hip arthroplasty under epidural anesthesia. Orthopedics 2010; 33(1): 17.
14. Imai N, Dohmae Y, Suda K, Miyasaka D, Ito T, Endo N. Tranexamic Acid for reduction of blood loss during total hip arthroplasty. J Arthroplasty 2012; 27(10): 1838-43.
15. Singh J, Ballal MS, Mitchell P, Denn PG. Effects of tranexamic acid on blood loss during total hip arthroplasty. J Orthop Surg 2010; 18(3): 282-6.
16. Chahal GS, Saithna A, Brewster M, et al. A Comparison of Complications Requiring Return to Theatre in Hip and Knee Arthroplasty Patients Taking Enoxaparin versus Rivaroxaban for Thromboprophylaxis. Ortop Traumatol Rehabil 2013; 2(6): 125-9.
17. Chmielewski D, Górecki A, Kusz D, Małdyk P, Marczyński W, Tomkowski W. Zasady profilaktyki żylnej choroby zakrze-powo-zatorowej w ortopedii i traumatologii narządu ruchu. Ortop Traumatol Rehabil 2014; 2(6): 227-39.
18. Drobniewski M, Borowski A, Synder M, Sibiński M. Wyniki całkowitej bezcementowej aloplastyki stawu biodrowego z zastosowaniem trzpienia Corail. Ortop Traumatol Rehabil 2013; 1(6): 61-8.
19. Oremus K, Sostaric S, Trkulja V, Haspl M. Influence of tranexamic acid on postoperative autologous blood retransfusion in primary total hip and knee arthroplasty: a randomized controlled trial. Transfusion 2014; 54(1): 31-41.
20. Sukeik M, Alshryda S, Haddad FS, Mason JM. Systematic review and meta-analysis of the use of tranexamic acid in total hip replacement. J Bone Joint Surg Br 2011; 93(1): 39-46.
21. Gandhi R, Evans HM, Mahomed SR, Mahomed NN. Tranexamic acid and the reduction of blood loss in total knee and hip arthroplasty: a meta-analysis. BMC Res Notes 2013; 6: 184.
22. Zhou XD, Tao LJ, Li J, Wu LD. Do we really need tranexamic acid in total hip arthroplasty? A meta-analysis of nineteen randomized controlled trials. Arch Orthop Trauma Surg 2013; 133(7): 1017-27.
23. Gillette BP, DeSimone LT, Trousdale RT, Pagnano MW, Sierra RJ. Low Risk of Thromboembolic Complications With Tranexamic Acid After Primary Total Hip and Knee Arthroplasty. Clin Orthop Relat Res 2013; 471(1): 150-4.